Genetic association between the lnterleukin-2 receptor-α gene and mode of onset of type 1 diabetes in the Japanese population

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 3, 2009, Pages 947-952

  Kawasaki, Eiji ^a   Awata, Takuya ^b   Ikegami, Hiroshi ^c   Kobayashi, Tetsuro ^d   Maruyama, Taro ^e   Nakanishi, Koji ^f   Shimada, Akira ^g   Uga, Miho ^a   Kurihara, Susumu ^b   Kawabata, Yumiko ^c   Tanaka, Shoichiro ^d   Kanazawa, Yasuhiko ^g   Eguchi, Katsumi ^h  

^a NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF YAMANASHI   (Japan)

^e Saitama Social Insurance Hospital   (Japan)

^f TORANOMON HOSPITAL   (Japan)

^g KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INTERLEUKIN 2 RECEPTOR ALPHA; HLA ANTIGEN CLASS 2;

ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JAPANESE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; STATISTICAL MODEL;

DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LOGISTIC MODELS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 62349109262     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-1596     Document Type: Article

References (24)

1. Kawasaki E, Gill RG, Eisenbarth GS 1999 Type 1 diabetes mellitus. In: Eisenbarth GS, ed. Molecular mechanisms of endocrine and organ specific autoimmunity. Austin, TX: R. G. Landes Co.; 149-182
2. Kawasaki E, Matsuura N, Eguchi K 2006 Type 1 diabetes in Japan. Diabetologia 49:828-836
3. Hakonarson H, Grant SF, Bradfield JP, Marchand L, Kim CE, Glessner JT, Grabs R, Casalunovo T, Taback SP, Frackelton EC, LawsonML, Robinson LJ, Skraban R, Lu Y, Chiavacci RM, Stanley CA, Kirsch SE, Rappaport EF, Orange JS, Memos DS, Devoto M, Qu HQ, Polychronakos C 2007 A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 448:591-594
4. Wellcome Trust Case Control Consortium 2007 Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:661-678
5. Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, Plagnol V, Bailey R, Nejentsev S, Field SF, Payne F, Lowe CE, Szeszko JS, Hafler JP, Zeitels L, Yang JH, Vella A, Nutland S, Stevens HE, Schuilenburg H, Coleman G, Maisuria M, Meadows W, Smink LJ, Healy B, Burren OS, Lam AA, Ovington NR, Allen J, Adlem E, Leung HT, Wallace C, Howson JM, Guja C, Ionescu-Tirgoviste C, Simmonds MJ, Heward JM, Gough SC, Dunger DB, Wicker LS, Clayton DG 2007 Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 39:857-864
6. Kim HP, Imbert J, Leonard WJ 2006 Both integrated and differential regulation of components of the IL-2/1L-2 receptor system. Cytokine Growth Factor Rev 17:349-366
7. Vella A, Cooper JD, Lowe CE, Walker N, Nutland S, Widmer B, Jones R, Ring SM, McArdle W, Pembrey ME, Strachan DP, Dunger DB, Twells RC, Clayton DG, Todd JA 2005 Localization of a type 1 diabetes locus in the 1L2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am J Hum Genet 76: 773-779
8. + T-cells from patients with type 1 diabetes. Diabetes 54:92-99
9. + T-cells in type 1 diabetes. Diabetes 54:1407-1414
10. Kobayashi M, Abiru N, Arakawa T, Fukushima K, Zhou H, Kawasaki E, Yamasaki H, Liu E, Miao D, Wong FS, Eisenbarth GS, Eguchi K 2007 Altered B:9-23 insulin, when administered intranasally with cholera toxin adjuvant, suppresses the expression of insulin autoantibodies and prevents diabetes. J Immunol 179:2082-2088
11. Lowe CE, Cooper JD, Brusko T, Walker NM, Smyth DJ, Bailey R, Bourget K, Plagnol V, Field S, Atkinson M, Clayton DG, Wicker LS, Todd JA 2007 Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nat Genet 39: 1074-1082
12. Ikegami H, Awata T, Kawasaki E, Kobayashi T, Maruyama T, Nakanishi K, Shimada A, Amemiya S, Kawabata Y, Kurihara S, Tanaka S, Kanazawa Y, Mochizuki M, Ogihara T 2006 The association of CTLA4 polymorphism with type 1 diabetes is concentrated in patients complicated with autoimmune thyroid disease: a multicenter collaborative study in Japan. J Clin Endocrinol Metab 91:1087-1092
13. Sera Y, Kawasaki E, Abiru N, OzakiM, Abe T, Takino H, Kondo H, Yamasaki H, Yamaguchi Y, Akazawa S, Nagataki S, Uchigata Y, Matsuura N, Eguchi K 1999 Autoantibodies to multiple islet autoantigens in patients with abrupt onset type 1 diabetes and diabetes diagnosed with urinary glucose screening. J Autoimmun 13:257-265
14. Kawasaki E, Uga M, Nakamura K, Kuriya G, Satoh T, Fujishima K, Ozaki M, Abiru N, Yamasaki H, Wenzlau JM, Davidson HW, Hutton JC, Eguchi K 2008 Association between anti-ZnT8 autoantibody specificities and SLC30A8 Arg325Trp variant in Japanese patients with type 1 diabetes. Diabetologia 51:2299-2302
15. Li SS, Khalid N, Carlson C, Zhao LP 2003 Estimating haplotype frequencies and standard errors for multiple single nucleotide polymorphisms. Biostatistics 4:513-522
16. Nakanishi K, Inoko H 2006 Combination of HLA-A24,-DQA1*03, and-DR9 contributes to acute-onset and early complete beta-cell destruction in type 1 diabetes: longitudinal study of residual β-cell function. Diabetes 55:1862-1868
17. Abe T, Yamaguchi Y, Takino H, Fujita N, Yamauchi DM, Ozaki M, Yamakawa K, Sera Y, Sakamaki H, Uotani S, Kawasaki E, Awata T, Yamasaki H, Eguchi K 2001 CTLA4 gene polymorphism contributes to the mode of onset of diabetes with antiglutamic acid decarboxylase antibody in Japanese patients: genetic analysis of diabetic patients with antiglutamic acid decarboxylase antibody. Diabet Med 18:726-731
18. Kawasaki E, Awata T, Ikegami H, Kobayashi T, Maruyama T, Nakanishi K, Shimada A, Uga M, Kurihara S, Kawabata Y, Tanaka S, Kanazawa Y, Lee I, Eguchi K 2006 Systematic search for single nucleotide polymorphisms in a lymphoid tyrosine phosphatase gene (PTPN22): association between a promoter polymorphism and type 1 diabetes in Asian populations. Am J Med Genet A 140:586-593
19. Yamada S, Motohashi Y, Yanagawa T, Maruyama T, Kasuga A, Hirose H, Matsubara K, Shimada A, Saruta T 2001 NeuroD/β2 gene G〉A polymorphism may affect onset pattern of type 1 diabetes in Japanese. Diabetes Care 24:1438-1441
20. Brand OJ, Lowe CE, Heward JM, Franklyn JA, Cooper JD, Todd JA, Gough SC 2007 Association of the interleukin-2 receptor α (IL-2Rα)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs. Clin Endocrinol (Oxf) 66:508-512
21. Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, De Jager PL, deBakker PI, Gabriel SB, Mirel DB, Ivinson AJ, Pericak-Vance MA, Gregory SG, Rioux JD, McCauley JL, Haines JL, Barcellos LF, Cree B, Oksenberg JR, Hauser SL 2007 Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357:851-862
22. Qu HQ, Montpetit A, Ge B, Hudson TJ, Polychronakos C 2007 Toward further mapping of the association between the IL2RA locus and type 1 diabetes. Diabetes 56:1174-1176
23. Harada R, Berube G, Tamplin OJ, Denis-Larose C, Nepveu A 1995 DNA binding specificity of the cut repeats from the human cut-like protein. Mol Cell Biol 15:129-140
24. Jackson RJ, Antonia SJ, Wright KL, Moon NS, Nepveu A, Munoz-Antonia T 1999 Human cut-like repressor protein binds TGFβ type II receptor gene promoter. Arch Biochem Biophys 371:290-300